Orum Therapeutics announced on the 3rd that it has finalized the public offering price for 2.5 million common shares at 20,000 won per share.
Orum Therapeutics' target public offering price range is 24,000 to 30,000 won per share. The finalized offering price is 20,000 won, approximately 16.7% lower than the lower end of the range, which is 24,000 won.
All public offering shares are newly issued shares directly issued by Orum Therapeutics. The general subscription period will take place from the 4th to 5th. The allocated shares for general investors amount to 625,000 shares. The planned listing date on the KOSDAQ is the 14th. The lead underwriter is Korea Investment & Securities.
Orum Therapeutics aims to raise a total of 50 billion won through this public offering. This figure is before deducting the lead underwriter's fees and other related expenses.
Earlier, Orum Therapeutics recorded a subscription rate of 16.93 to 1 in the demand forecast conducted for institutional investors from the 17th to 23rd of last month. A total of 371 institutions participated in the forecast. Among them, 71.16% (264 institutions) presented prices below the lower end of the public offering price range (24,000 to 30,000 won).